قياس مستويات الألدوستيرون والأنجيوتنسين II وبعض المتغيرات الكيموحيوية في مصل الدم لدى مرضى ارتفاع ضغط الدم
DOI:
https://doi.org/10.54153/sjpas.2025.v7i2.957الكلمات المفتاحية:
ارتفاع ضغط الدم، الالدوستيرون، اليوريا، ضغط الدمالملخص
في هذا العمل، تم قياس مستويات الألدوستيرون والأنجيوتنسين II ومتغيرات كيميائية حيوية مختلفة في مصل الدم للأشخاص الذين يعانون من ارتفاع ضغط الدم ومقارنتها بمجموعة السيطرة. تم تقدير مستويات الألدوستيرون والأنجيوتنسين II واليوريا والكرياتين والصوديوم والبوتاسيوم لدى مرضى ارتفاع ضغط الدم. أظهرت النتائج الإحصائية زيادة ملحوظة في معدلات هرمون الألدوستيرون والصوديوم لدى مرضى ارتفاع ضغط الدم لكلا الجنسين مقارنة بمجموعة السيطرة. علاوة على ذلك، أظهرت النتائج زيادة كبيرة في هرمون الأنجيوتنسين II ومعدل اليوريا لدى المرضى الذكور المصابين بارتفاع ضغط الدم مقارنة بمجموعة السيطرة؛ ومع ذلك، لم تظهر فروق ذات دلالة إحصائية في المرضى الإناث مقارنة بالأشخاص الأصحاء. وأظهرت النتائج انخفاضا كبيرا في معدل البوتاسيوم. ومع ذلك، لم تظهر النتائج اختلافا كبيرا في معدلات الكرياتين وحمض اليوريك لدى كلا الجنسين، الأفراد الذين يعانون من ارتفاع ضغط الدم، مقارنة بمجموعة السيطرة.
المراجع
1. Demikhov, O., et al., Arterial hypertension prevention as an actual medical and social problem. Bangladesh Journal of Medical Science, 2020. 19(4): p. 722-729.
2. Mohammed, M.M., S.M.S. Hassan, and E.M. Mustafa, Epidemiological study of hypertensive cases among teaching staffs in kirkuk university. Journal of Kirkuk University–Scientific Studies, 2010. 5(1).
3. Martyniak, A. and P.J. Tomasik, A new perspective on the renin-angiotensin system. Diagnostics, 2022. 13(1): p. 16.
4. Kesireddy, V., et al., The association of Life’s Simple 7 with aldosterone among African Americans in the Jackson Heart Study. Nutrients, 2019. 11(5): p. 955.
5. Gounden, V., H. Bhatt, and I. Jialal, Renal function tests. 2018.
6. Mohiuddin, S.S. and D. Khattar, Biochemistry, ammonia. 2019.
7. Faye, B., et al., Nitrogen and Protein Parameters. Camel Clinical Biochemistry and Hematology, 2018: p. 81-122.
8. Ebert, N., et al., Assessment of kidney function: clinical indications for measured GFR. Clinical kidney journal, 2021. 14(8): p. 1861-1870.
9. Clarke, H.E., Impact of Creatine Supplementation on Vascular Endothelial Function, Blood Flow and Functional Capacity in Older Adults. 2021: The Florida State University.
10. Bonilla, D.A., et al., Metabolic basis of creatine in health and disease: a bioinformatics-assisted review. Nutrients, 2021. 13(4): p. 1238.
11. Gutmann, I. and H.U. Bergmeyer, Urea, in Methods of enzymatic analysis. 1974, Elsevier. p. 1791-1801.
12. Kawyn, M., Pyrethroid and Chlorpyrifos Exposure and IQ of Children from the Salud Ambiental Montevideo (Sam) Study in Uruguay. 2020, State University of New York at Buffalo.
13. Fossati, P., L. Prencipe, and G. Berti, Use of 3, 5-dichloro-2-hydroxybenzenesulfonic acid/4-aminophenazone chromogenic system in direct enzymic assay of uric acid in serum and urine. Clinical chemistry, 1980. 26(2): p. 227-231.
14. Henry, R.J., Clinical chemistry, principles and technics. 1964.
15. Nalbandian, R.M., et al., Dithionite tube test—a rapid, inexpensive technique for the detection of hemoglobin S and non-S sickling hemoglobin. Clinical chemistry, 1971. 17(10): p. 1028-1032.
16. Vasan, R.S., et al., Serum aldosterone and the incidence of hypertension in nonhypertensive persons. New England Journal of Medicine, 2004. 351(1): p. 33-41.
17. Gideon, A., Aldosterone—an Intermediate Factor Linking Psychosocial Stress to Essential Hypertension. 2024.
18. Velez, J.C.Q., et al., Lack of renoprotective effect of chronic intravenous angiotensin-(1-7) or angiotensin-(2-10) in a rat model of focal segmental glomerulosclerosis. PLoS One, 2014. 9(10): p. e110083.
19. Harvey, P.J., et al., Estradiol induces discordant angiotensin and blood pressure responses to orthostasis in healthy postmenopausal women. Hypertension, 2005. 45(3): p. 399-405.
20. Yanes, L.L., et al., Testosterone-dependent hypertension and upregulation of intrarenal angiotensinogen in Dahl salt-sensitive rats. American Journal of Physiology-Renal Physiology, 2009. 296(4): p. F771-F779.
21. Yang, Q., et al., Homocysteine level is positively and independently associated with serum creatinine and urea nitrogen levels in old male patients with hypertension. Scientific Reports, 2020. 10(1): p. 18050.
22. Ljungman, S., et al., Blood pressure and renal function. Acta Medica Scandinavica, 1980. 208(1‐6): p. 17-25.
23. Burits, C. and E. Ashwood, Renal Function and Nitrogen Metabolism. Tietz Fundamental Clinical Chemistry. 5th ed. McGraw Hill, 2001: p. 414-426.
24. Duni, A., et al., Hypertension in chronic kidney disease: novel insights. Current Hypertension Reviews, 2020. 16(1): p. 45-54.
25. Alqudsi, M., S. Hiremath, and J.C.Q. Velez, Review–current opinion in cardiology hypertension in chronic kidney disease. Current Opinion in Cardiology, 2020. 35(4): p. 360-367.
26. Li, L., et al., Is hyperuricemia an independent risk factor for new-onset chronic kidney disease?: a systematic review and meta-analysis based on observational cohort studies. BMC nephrology, 2014. 15: p. 1-12.
27. Lv, Q., et al., High serum uric acid and increased risk of type 2 diabetes: a systemic review and meta-analysis of prospective cohort studies. PloS one, 2013. 8(2): p. e56864.
28. Jensen, T., et al., Fructose and sugar: A major mediator of non-alcoholic fatty liver disease. Journal of hepatology, 2018. 68(5): p. 1063-1075.
29. Stewart, P.M., Mineralocorticoid hypertension. The Lancet, 1999. 353(9161): p. 1341-1347.
30. Bailey, M.A. and N. Dhaun, Salt sensitivity: causes, consequences, and recent advances. Hypertension, 2024. 81(3): p. 476-489.
31. Lever, A., et al., Sodium and potassium in essential hypertension. Br Med J (Clin Res Ed), 1981. 283(6289): p. 463-468.
32. Rinner, M.D., L. Spliet-van Laar, and D. Kromhout, Serum sodium, potassium, calcium and magnesium and blood pressure in a Dutch population. Journal of hypertension, 1989. 7(12): p. 977-981.
33. Bulpitt, C., M. Shipley, and A. Semmence, Blood pressure and plasma sodium and potassium. Clinical Science, 1981. 61(s7): p. 85s-87s.
34. Gupta, R., et al., Prevalence and determinants of hypertension in the urban population of Jaipur in western India. Journal of hypertension, 1995. 13(10): p. 1193-1200.
35. Malhotra, P., et al., Prevalence and determinants of hypertension in an un-industrialised rural population of North India. Journal of human hypertension, 1999. 13(7): p. 467-472.
36. Pikilidou, M.I., et al., Blood pressure and serum potassium levels in hypertensive patients receiving or not receiving antihypertensive treatment. Clinical and Experimental Hypertension, 2007. 29(8): p. 563-573.
التنزيلات
منشور
إصدار
القسم
الرخصة
هذا العمل مرخص بموجب Creative Commons Attribution 4.0 International License.
Copyright Notice
Authors retain copyright and grant the SJPAS journal right of first publication, with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in Samarra Journal of Pure and Applied Science.
The Samarra Journal of Pure and Applied Science permits and encourages authors to archive Pre-print and Post-print items submitted to the journal on personal websites or institutional repositories per the author's choice while providing bibliographic details that credit their submission, and publication in this journal. This includes the archiving of a submitted version, an accepted version, or a published version without any Risks.
